newsfilter
← Latest News
Business Wire·

Aptinyx to Present at the SVB Securities Global Biopharma Conference

Aptinyx Inc. (NASDAQ:APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that Andy Kidd, M.D., president &